VIVO 33.97 (+0%)
US5895841014Medical Diagnostics & ResearchDiagnostics & Research

Meridian Bioscience (VIVO) Competitor Comparison

We are evaluating the key criteria listed to compare Meridian Bioscience (VIVO) against its competitors in the Diagnostics & Research industry.

Valuation Rank - VIVO ranking 41 / 58

These are the competitors of Meridian Bioscience in the industry Diagnostics & Research ranked by valuation rank
1. Charles River Laboratories CRL
0.86
2. Laboratory Corp of America Holdings LH
0.86
3. Quest Diagnostics DGX
0.79
4. Neogen NEOG
0.71
5. NeoGenomics NEO
0.71
6. Bioventus BVS
0.71
7. CareDx CDNA
0.71
8. Syneos Health SYNH
0.64
9. Exagen XGN
0.64
10. Sotera Health SHC
0.64
11. RadNet RDNT
0.64
12. DarioHealth DRIO
0.64
13. Icon ICLR
0.64
14. Medpace Holdings MEDP
0.57
15. Enzo Biochem ENZ
0.57
16. Global Cord Blood CO
0.57
17. Inotiv NOTV
0.57
18. IQVIA Holdings IQV
0.57
19. Lantheus Holdings LNTH
0.57
20. Qiagen QGEN
0.57
21. Thermo Fisher Scientific TMO
0.57
22. Twist Bioscience TWST
0.57
23. Guardant Health GH
0.5
24. Exact Sciences EXAS
0.5
25. DexCom DXCM
0.5
26. MaxCyte MXCT
0.5
27. Illumina ILMN
0.5
28. Myriad Genetics MYGN
0.5
29. National Research NRC
0.5
30. Danaher DHR
0.5
31. Co-Diagnostics CODX
0.5
32. Olink Holding OLK
0.5
33. IDEXX Laboratories IDXX
0.5
34. Personalis PSNL
0.5
35. bioAffinity Technologies BIAF
0.5
36. Fulgent Genetics FLGT
0.5
37. Trinity Biotech TRIB
0.43
38. Organovo Holdings ONVO
0.43
39. Waters WAT
0.43
40. Heska HSKA
0.43
41. Meridian Bioscience VIVO
0.43
42. Mettler-Toledo MTD
0.43
43. Prenetics Global PRE
0.43
44. Natera NTRA
0.43
45. Biodesix BDSX
0.43
46. Sera Prognostics SERA
0.43
47. Pacific Biosciences of California PACB
0.36
48. Psychemedics PMD
0.36
49. Interpace Biosciences IDXG
0.29
50. Anixa Biosciences ANIX
0.29
51. PerkinElmer PKI
0.29
52. Neuronetics STIM
0.29
53. Precipio PRPO
0.29
54. MDxHealth MDXH
0.29
55. Ortho Clinical Diagnostics Holdings OCDX
0.14
56. SeqLL SQL
0.14
57. Aspira Womens Health AWH
0.07
58. Agilent Technologies A
0.07

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.